ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$345.74
-1.24 (-0.36%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Apr 21, 2026
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ELV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ELV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$619.36
Based on 9.6% avg growth
INTRINSIC VALUE TODAY
$384.57
10.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $345.74, which is considered slightly low relative to its 30-day fair value range of $345.53 to $374.78. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.5) compared to its historical average (13.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This pessimistic expectation contrasts with the company's recent 36.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $315.46, while resistance sits at $381.18.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $392.65 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $315.46, while resistance sits at $381.18.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $392.65 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$345.53 -
$374.78
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
Protect Your Profits
Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($392.65)
- CAUTION: Recommendation downgraded due to -6.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$345.53 -
$374.78
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$315.46
Resistance Level
$381.18
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
11.50
Wall Street Target
$392.65
(+13.6%)
Revenue Growth (YoY)
9.5%
Earnings Growth (YoY)
36.3%
Profit Margin
2.8%
Valuation Discount vs History
-4.2% cheaper
PE vs Historical
11.5 vs 13.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.2%
(market-implied from PE analysis)
1-Year Target
$331.22
(-4%)
2-Year Target
$317.31
(-8%)
3-Year Target
$303.98
(-12%)
3-Yr Target (if PE normalizes)
(PE: 12→13)
$346.23
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 15.1%)
$1022.73
(+196%)
Base:
(SPY PE: 11.5, Growth: 15.1%)
$527.48
(+53%)
Bear:
(PE: 9.8, Growth: 15.1%)
$448.36
(+30%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 13.57 | Current EPS (TTM): $25.19
Bull Case
$463.89
(+34%)
Analyst growth 23.4%, PE expands to 14.9
Base Case
$421.72
(+22%)
Market implied 23.4%, PE stable at 13.6
Bear Case
$232.46
(-33%)
Severe decline -20.0%, PE contracts to 11.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.5 to 13.1
Stabilization Target:
$393.80
(+13.9%)
PE Expansion Potential:
+13.9%
Last updated: January 31, 2026 11:40 PM ET
Data refreshes hourly during market hours. Next update: 12:40 AM
Data refreshes hourly during market hours. Next update: 12:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
5
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ro Khanna
BUY
2025-09-29
Ro Khanna
BUY
2025-09-05
Ro Khanna
BUY
2025-08-26
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$95 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$327 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$44 | 53 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
